Adapting to Data Integration and AI

Feldman expects “critical progress in data integration will bring about major improvements in healthcare,” including enabling patients “access to their complete longitudinal health records on their phones.” 

Patients Embracing Telehealth

Telehealth and virtual visits have become and will continue to be much more common in 2023, as patients like the convenience. 

Advancing mRNA Technology

Few people had heard about the synthetic messenger RNA genetic technology prior to the COVID-19 pandemic when this medical technology was used to create mRNA vaccines, which have been highly effective at reducing hospitalizations and deaths from the SARS-CoV-2 virus. 

Speedier sepsis detection

Blood clots, leaking blood vessels, and organ damage all are possible outcomes of sepsis, the body’s extreme reaction to an infection. Each year in the United States, 1.7 million U.S. adults develop sepsis, and at least 350,000 either die in the hospital or are sent to hospice because of it.

Delaying diabetes by years

Now the medication teplizumab delays onset of the condition by an average of two years — and sometimes by more than a decade, says Kevan Herold, MD, a principal investigator of the drug and an immunologist at Yale Medicine in New Haven, Connecticut.

Record-breaking gene sequencing

Gene sequencing to map a patient’s DNA can be crucial to identifying causes of life-threatening conditions. And doing so rapidly can reduce the need for other tests, cut the time patients spend in the hospital, and expedite vital precision treatments.

RSV vaccine

Respiratory syncytial virus (RSV) made headlines this winter for its role in the tripledemic that, together with COVID-19 and flu, slammed many U.S. hospitals. But now there’s some good news related to RSV: On May 3, the Food and Drug Administration (FDA) gave its first-ever approval to a vaccine that protects against the dangerous condition.